InvestSMART

Emyria Limited (ASX: EMD) - Announcements

Current share price for EMD : $0.039 0.003 (7.14%)+

ASX company news and announcements for Emyria Limited (EMD) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Emyria Limited (EMD) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Emyria Limited (EMD), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Emyria Limited (EMD)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$31 Notification of cessation of securities - EMD 22 Sep 2025 11:07AM $0.056 $0.039 fallen by 30.36%
$31 Emyria Secures Medibank Funding for Depression Care Program 22 Sep 2025 9:40AM $0.050 $0.039 fallen by 22%
$31 EMD Completes Sale of Less than Marketable Parcel at Premium 15 Sep 2025 8:56AM $0.047 $0.039 fallen by 17.02%
$31 Notice to Ineligible Shareholders of Loyalty Options Offer 15 Sep 2025 8:21AM $0.047 $0.039 fallen by 17.02%
$31 Notice to Eligible Shareholders of Loyalty Options Offer 9 Sep 2025 8:34AM $0.044 $0.039 fallen by 11.36%
$31 Loyalty Options Prospectus 9 Sep 2025 8:22AM $0.044 $0.039 fallen by 11.36%
$31 Change in substantial holding 8 Sep 2025 8:21AM $0.049 $0.039 fallen by 20.41%
$31 Change of Director's Interest Notice x 2 1 Sep 2025 2:09PM $0.045 $0.039 fallen by 13.33%
$31 Section 708A(5)(e) Notice 29 Aug 2025 6:20PM $0.048 $0.039 fallen by 18.75%
$31 Application for quotation of securities - EMD 29 Aug 2025 6:18PM $0.048 $0.039 fallen by 18.75%
$31 Notification regarding unquoted securities - EMD 29 Aug 2025 6:18PM $0.048 $0.039 fallen by 18.75%
$31 Emyria Expansion & Strategic Update Webinar Presentation 28 Aug 2025 9:12AM $0.050 $0.039 fallen by 22%
$31 Appendix 4E & Annual Report for the Year Ended 30 June 2025 28 Aug 2025 9:03AM $0.050 $0.039 fallen by 22%
$31 2025 Annual General Meeting - Key Dates 28 Aug 2025 8:55AM $0.050 $0.039 fallen by 22%
$31 Investor Webinar Invitation 27 Aug 2025 8:10AM $0.053 $0.039 fallen by 26.42%
$31 Emyria to Expand Perth Clinic to Meet Growing Demand 26 Aug 2025 9:46AM $0.046 $0.039 fallen by 15.22%
$31 Results of Meeting 19 Aug 2025 5:55PM $0.043 $0.039 fallen by 9.30%
$31 Emyria Commences National Expansion with Avive in Brisbane 29 Jul 2025 8:28AM $0.041 $0.039 fallen by 4.88%
$31 June 2025 Quarterly Activities Report and Appendix 4C 28 Jul 2025 9:55AM $0.041 $0.039 fallen by 4.88%
$31 Update - Proposed issue of securities - EMD 25 Jul 2025 5:49PM $0.041 $0.039 fallen by 4.88%
$31 Update on Bonus Loyalty Options Offer 25 Jul 2025 5:36PM $0.041 $0.039 fallen by 4.88%
$31 Less than Marketable Parcel Sale Facility 18 Jul 2025 10:50AM $0.034 $0.039 risen by 14.71%
$31 Letter to Shareholders - Notice of General Meeting 18 Jul 2025 10:42AM $0.034 $0.039 risen by 14.71%
$31 Notice of General Meeting/Proxy Form 18 Jul 2025 10:42AM $0.034 $0.039 risen by 14.71%
$31 Ceasing to be a substantial holder 30 Jun 2025 8:22AM $0.027 $0.039 risen by 44.44%

101 - 125 of 573 results

Page 5 of 23

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.